Abstral 100 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 100 mikrogram resoriblett, sublingual

medartuum ab - fentanylcitrat - resoriblett, sublingual - 100 mikrogram - fentanylcitrat 157,1 mikrog aktiv substans; mannitol hjälpämne - fentanyl

Abstral 200 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 200 mikrogram resoriblett, sublingual

medartuum ab - fentanylcitrat - resoriblett, sublingual - 200 mikrogram - fentanylcitrat 314,2 mikrog aktiv substans; mannitol hjälpämne - fentanyl

Abstral 200 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 200 mikrogram resoriblett, sublingual

orifarm ab - fentanylcitrat - resoriblett, sublingual - 200 mikrogram - mannitol hjälpämne; fentanylcitrat 314,2 mikrog aktiv substans - fentanyl

Abstral 300 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 300 mikrogram resoriblett, sublingual

medartuum ab - fentanylcitrat - resoriblett, sublingual - 300 mikrogram - fentanylcitrat 471,3 mikrog aktiv substans; mannitol hjälpämne - fentanyl

Abstral 400 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 400 mikrogram resoriblett, sublingual

medartuum ab - fentanylcitrat - resoriblett, sublingual - 400 mikrogram - fentanylcitrat 628,4 mikrog aktiv substans; mannitol hjälpämne - fentanyl

Zinforo Europese Unie - Zweeds - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakteriella medel för systemiskt bruk, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.

Abstral 100 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 100 mikrogram resoriblett, sublingual

orifarm ab - fentanylcitrat - resoriblett, sublingual - 100 mikrogram - mannitol hjälpämne; fentanylcitrat 157,1 mikrog aktiv substans

Abstral 300 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 300 mikrogram resoriblett, sublingual

medartuum ab - fentanylcitrat - resoriblett, sublingual - 300 mikrogram - mannitol hjälpämne; fentanylcitrat 471,3 mikrog aktiv substans

Abstral 200 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 200 mikrogram resoriblett, sublingual

medartuum ab - fentanylcitrat - resoriblett, sublingual - 200 mikrogram - mannitol hjälpämne; fentanylcitrat 314,2 mikrog aktiv substans

Abstral 100 mikrogram Resoriblett, sublingual Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

abstral 100 mikrogram resoriblett, sublingual

medartuum ab - fentanylcitrat - resoriblett, sublingual - 100 mikrogram - mannitol hjälpämne; fentanylcitrat 157,1 mikrog aktiv substans